Asthma is the most common chronic disease in children, affecting 1 in 11 children in the UK.

Inhaled corticosteroids (ICS) form the foundation of asthma management, with well-controlled asthma associated with little or no need for short-acting bronchodilators (ie, salbutamol).1 Research consistently highlights that non-adherence to preventer inhalers is associated with poor outcomes1; the number of ICS canisters used per year is inversely related to the rate of death due to asthma. …

Source link